
ESOP16 Nov 2026, 05:30 pm
Gland Pharma Grants 85,317 Stock Options to 2 Employees
AI Summary
Gland Pharma Ltd announced the grant of 85,317 Employee Stock Options under its ESOP 2025 scheme to two employees. The grant, approved by the ESOP Compensation Committee, aligns with SEBI regulations. Options are priced at INR 1,692.95 for 56,309 grants (50% of NSE closing price on Nov 16, 2026) and INR 1 for the remaining 29,008 grants. Vesting will occur in tranches over three years, starting November 16, 2027, with options exercisable within two years of vesting.
Key Highlights
- 85,317 stock options granted to 2 employees.
- Grant priced at INR 1,692.95 and INR 1 per option.
- Vesting over three years from November 16, 2027.
- Options exercisable within two years post-vesting.
- Scheme complies with SEBI (Share Based Employee Benefits) Regulations.
Price Impact
More from GLAND